FDA Inspection 1246222 — Danville Regional Medical Center
The FDA completed an inspection of Danville Regional Medical Center on July 30, 2024 in Danville, VA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 30, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Danville, VA (United States)